← Back
$JANX All transactions

Janux Therapeutics, Inc.

A

$ Value

$0

Shares

44,000

Price

$0

Filed

Jun 4

Insider

Name

Doyle Janeen Noel

Title

Chief Corp. & Bus. Dev. Ofcr

CIK

0002069239

Roles

Officer

Transaction Details

Transaction Date

2025-06-02

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

44,000

Footnotes

Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on June 1, 2026. | 25% of the shares subject to the option vest on May 14, 2026 and the balance will vest in equal monthly installments thereafter over a three year period.

Filing Info

Accession No.

0001415889-25-015684

Form Type

4

Issuer CIK

0001817713

Doyle Janeen Noel's History

Date Ticker Type Value
2026-01-02 JANX A $0
2026-01-02 JANX A $0
2025-06-02 JANX A $0
2025-06-02 JANX A $0

Other Insiders at JANX (90d)

Insider Bought Sold Last
Go William
Chief Medical Officer
2026-02-02